Blockchain Short Reports

Blockchain Short Reports2020-05-06T07:36:37-04:00


Welcome to our Short Reports. Since late January 2020, all of our short reports are timestamped with blockchain technology.You can now verify to the second when a new Short Report is published and the share price at that specific point in time. The blockchain timestamps are proof of the time of publishing and content of these articles as explained below.

The companies featured on our short reports have been selected through a set of variables established by our proprietary machine learning AI and database,”Asgard”.  Asgard could thus be described as stock a selection tool that identifies high-probability fraudulent/dubious tickers and ascertains high-profitability trading entry and exit points. For more information check out our about page.

What are blockchain timestamps?

Our content is timestamped with WordProof Timestamp, which is why you might see a notification that looks like this on some of our pages:

Because of this, you (as a visitor) can verify that what we wrote and published is actually shown on the webpage: it is impossible for us (or anyone else) to tamper with the information. For each page, a fingerprint is generated (the hash), which is added to a blockchain transaction. Because of the immutability of the blockchain, this transaction (and the fingerprint) can’t be modified or removed. Thus, you know for sure (and can verify yourself) that our content was written at the indicated time.

If you are not familiar with Blockchain you can read the details here.




CytoDyn, Inc. OTCQB: CYDY Short Report, 9:30am April 14, 2020

April 14th, 2020|

Intro: On February 6, 2020, we published our first short report on CYDY. In this report we highlighted many of the red flags this company raises such as: significant dilution during 2019; a promissory note issued to one of the most prolific so-called “vulture funds” currently operating among USA small/micro/nano caps; an underwriter with a less than stellar FINRA broker check record; terrible financials. At the time of publication, the price per [...]

SCWorx Corp. Nasdaq: WORX Short Report, 8:50am April 14, 2020

April 14th, 2020|

Intro: Yesterday, SCWorx Corp.’s share price enjoyed a remarkable parabolic run, increasing by more than five-fold. Volume was also remarkable, exceeding 90 million shares traded, which is ridiculous when one bears in mind that the number of outstanding shares does not even reach 8 million. Given this highly unusual market activity we decided to take a closer look at WORX and unsurprisingly we found enough red flags to warrant putting out a [...]

Akers Biosciences Inc. Nasdaq: AKER Short report 9:40am, April 7, 2020

April 7th, 2020|

Intro: Another week, another short report on a so-called “dubious” publicly traded company. This week it is Akers Biosciences, Inc.’s turn. Yesterday, its share price closed 147% higher than last week’s closing price and trading volume saw an all-time record level surpassing 57 million. This volume is simply ridiculous when one bares in mind that the number of outstanding shares stood at 540,000 on December 31, 2019. Like many of the other [...]

U.S Gold Corp. Nasdaq: USAU Short Report, 9:40am March 26, 2020

March 26th, 2020|

Intro: Like most of the tickers featured in our short reports U.S Gold Corp. has exhibited a combination of a drastic price increase (over a two-fold price increase over the last 2 days) and trading volume substantially above the 30-day daily average (770 thousand vs 33 thousand). One might argue that this is not a particularly strange occurrence in the world of nano caps in light of the increased demand for gold [...]

Anavex Life Sciences Corp. OTCQB: AVXL Short Report, 9:40am February 19, 2020

February 19th, 2020|

Intro: Like all other tickers featured in our short reports, AVXL’s has exhibited unusual behaviour recently, with its price per share more than doubling over the last three weeks. Furthermore, daily trading volume has been considerably above the 6-month daily average and RSI (14) has breached 85. Anavex has gotten itself into a fair number of headlines over recent years, so it didn’t take much digging around to find enough material for [...]

Agile Therapeutics, Inc. Nasdaq: AGRX Short Report, 9:30am February 18, 2020

February 18th, 2020|

Intro: Since early November 2019, Agile Therapeutics, Inc’s share price has seen a four-fold increase and daily trading volume has picked up significantly. We believe this to be rather suspicious, especially when considering other red flags, such as: serious dilution issues over the last year or so, a loan agreement with a “spiral of death” creditor, a loan facility with a well-known yet dubious institutional shareholder , and a CEO that has [...]

%d bloggers like this: